Latest Articlesddd
Karyopharm Therapeutics Third Quarter Financial Results Generated Revenues For the first time since its establishment Karyopharm …
Compugen FDA Approval for COM902 Compugen Announces FDA Clearance of IND Application for COM902 Phase 1 …
The Week in Review #46 The Quarterly Financial Results The quarterly financial results that analysts and …
IVERIC bio Stock Outperforms IVERIC bio (ISEE) has good news its stock is responding to. A …
Regenxbio Misleading Selloff A selloff of Regenxbio (RGNX) stock, following the FDA’s partial hold on the …
The Week in Review #44 Quarterly Financial Results What Was Seen and What Was Ignored History …
Spring Bank Pharmaceuticals, Gilead Sciences and HBV If Spring Bank Pharmaceuticals’ (SBPH) product inarigivir in combination …
The Week in Review #43 This Past Week After hearing hints about the trade war between …
Seattle Genetics Announced Positive Results for HER2CLIMB Trial Seattle Genetics (SGEN) announced positive topline results from …
Bayer Decision to Advance IONIS-FXI-LRx for Clotting Disorders On October 9, 2019 Ionis Pharmaceuticals (IONS) announced …
Hepion Pharmaceuticals CRV431 Decreased Liver Fibrosis and Tumor Burden in Experimental Models EDISON, NJ / ACCESSWIRE …
Reata Pharmaceuticals Omaveloxolone for Friedreich’s Ataxia On October 14, 2019 Reata Pharmaceuticals (RETA) announced the Part 2 …
RegenxBio Rebounding RegenxBio (RGNX) has the viral vectors which could safely deliver genes into the cells. …
RegenxBio Interim Data from Phase I/IIa Trial of RGX-314 for Wet AMD RegenxBio (RGNX) announced interim …
Stock Market Volatility Stocks can move up and down for various reasons but not all of …
Nektar Therapeutics Announces Two Studies of NKTR-358 Nektar Therapeutics (NKTR) announced the initiation of two Phase 1b …
The Week in Review #42 During the Departed Week The week started with the market losing …
Prohost Letter #436 What Are We Experiencing Now? The bizarre market underperformance progressing rather than regressing …
Seattle Genetics Stock Rally Seattle Genetics (SGEN) stock has rallied today. It gained around $10; trading …
Enanta Positive Results of EPD-305 for NASH Enanta (ENTA) has positive results from the ARGON-1 Phase …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
